Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Saenger

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Current Opinion in Endocrinology, Diabetes, and Obesity|July 3, 2008
Safety and efficacy of growth hormone treatment in small for gestational age childrenAruna Poduval, Paul Saenger
Pediatric Investigation|March 27, 2023
Long-acting growth hormone in 2022Margaret Steiner, Jacklyn Frank, Paul Saenger
Frontiers in Pediatrics|October 16, 2023
Long acting growth hormone (LAGH), an updateMargaret Steiner Grillo, Jacklyn Frank, Paul Saenger
Journal of Pediatric Endocrinology & Metabolism : JPEM|July 29, 2008
Predictors of first-year growth response to a fixed-dose growth hormone treatment in children born small for gestational age: results of an open-label, multicenter trial in the United StatesRobert Rapaport, Paul Saenger, Michael P Wajnrajch, et al.
Hormone Research|October 10, 2006
Unique deletion in exon 5 of SHOX gene in a patient with idiopathic short statureAlan L Shanske, Mala Puri, Barbara Marshall, et al.
Endocrine Reviews|February 27, 2007
Small for gestational age: short stature and beyondPaul Saenger, Paul Czernichow, Ieuan Hughes, et al.
Hormone Research|March 22, 2006
Prediction models for insulin resistance in girls with premature adrenarche. The premature adrenarche insulin resistance score: PAIR scorePatricia Vuguin, Gabriela Grinstein, Katherine Freeman, et al.
European Journal of Endocrinology|March 25, 2010
Bioequivalence between novel ready-to-use liquid formulations of the recombinant human GH Omnitrope and the original lyophilized formulations for reconstitution of Omnitrope and GenotropinUwe Fuhr, Daniel Tuculanu, Alexander Berghout, et al.
Endocrine Connections|August 25, 2018
Three years of growth hormone therapy in children born small for gestational age: results from the ANSWER ProgramRobert Rapaport, Peter Lee, Judith Ross, et al.
Journal of Clinical Research in Pediatric Endocrinology|October 15, 2025
Measurement of 11-Oxo-Androgens, A Novel Biomarker, in Females with Clinical Signs of Premature AdrenarcheLiana Gabriel, Jorge Mejia-Corletto, Beatriz Blinov, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Current Opinion in Endocrinology, Diabetes, and Obesity|July 3, 2008
Safety and efficacy of growth hormone treatment in small for gestational age childrenAruna Poduval, Paul Saenger
Pediatric Investigation|March 27, 2023
Long-acting growth hormone in 2022Margaret Steiner, Jacklyn Frank, Paul Saenger
Frontiers in Pediatrics|October 16, 2023
Long acting growth hormone (LAGH), an updateMargaret Steiner Grillo, Jacklyn Frank, Paul Saenger
Journal of Pediatric Endocrinology & Metabolism : JPEM|July 29, 2008
Predictors of first-year growth response to a fixed-dose growth hormone treatment in children born small for gestational age: results of an open-label, multicenter trial in the United StatesRobert Rapaport, Paul Saenger, Michael P Wajnrajch, et al.
Hormone Research|October 10, 2006
Unique deletion in exon 5 of SHOX gene in a patient with idiopathic short statureAlan L Shanske, Mala Puri, Barbara Marshall, et al.
Endocrine Reviews|February 27, 2007
Small for gestational age: short stature and beyondPaul Saenger, Paul Czernichow, Ieuan Hughes, et al.
Hormone Research|March 22, 2006
Prediction models for insulin resistance in girls with premature adrenarche. The premature adrenarche insulin resistance score: PAIR scorePatricia Vuguin, Gabriela Grinstein, Katherine Freeman, et al.
European Journal of Endocrinology|March 25, 2010
Bioequivalence between novel ready-to-use liquid formulations of the recombinant human GH Omnitrope and the original lyophilized formulations for reconstitution of Omnitrope and GenotropinUwe Fuhr, Daniel Tuculanu, Alexander Berghout, et al.
Endocrine Connections|August 25, 2018
Three years of growth hormone therapy in children born small for gestational age: results from the ANSWER ProgramRobert Rapaport, Peter Lee, Judith Ross, et al.
Journal of Clinical Research in Pediatric Endocrinology|October 15, 2025
Measurement of 11-Oxo-Androgens, A Novel Biomarker, in Females with Clinical Signs of Premature AdrenarcheLiana Gabriel, Jorge Mejia-Corletto, Beatriz Blinov, et al.
Pageof 5